https://www.taxtmi.com/news?id=20015 Regulatory reforms extend the validity of the Good Manufacturing Practices Certificate and establish a clinical trial approval timeline whereby an application not decided within the prescribed period will be deemed approved, aiming to reduce regulatory delay, ensure consistent product quality, and enhance export competitiveness for Indian pharmaceuticals. en-us Tue, 08 May 2018 18:27:09 +0530 Tue, 08 May 2018 18:29:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=20015 Regulatory reforms extend the validity of the Good Manufacturing Practices Certificate and establish a clinical trial approval timeline whereby an application not decided within the prescribed period will be deemed approved, aiming to reduce regulatory delay, ensure consistent product quality, and enhance export competitiveness for Indian pharmaceuticals. News - Tue, 08 May 2018 18:27:09 +0530 https://www.taxtmi.com/news?id=20015